These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 36945423)

  • 61. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
    Nyberg T; Ferguson NM; Nash SG; Webster HH; Flaxman S; Andrews N; Hinsley W; Bernal JL; Kall M; Bhatt S; Blomquist P; Zaidi A; Volz E; Aziz NA; Harman K; Funk S; Abbott S; ; Hope R; Charlett A; Chand M; Ghani AC; Seaman SR; Dabrera G; De Angelis D; Presanis AM; Thelwall S
    Lancet; 2022 Apr; 399(10332):1303-1312. PubMed ID: 35305296
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Vaccination Intention Following Receipt of Vaccine Information Through Interactive Simulation vs Text Among COVID-19 Vaccine-Hesitant Adults During the Omicron Wave in Germany.
    Wegwarth O; Mansmann U; Zepp F; Lühmann D; Hertwig R; Scherer M
    JAMA Netw Open; 2023 Feb; 6(2):e2256208. PubMed ID: 36795411
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High vaccine effectiveness against severe COVID-19 outcomes and population preventable fraction during the Omicron era in Luxembourg: A nationwide retrospective risk factor analysis.
    Bejko D; Ernst C; Vergison A; Stranges S; Zeegers MP; Mossong J
    Vaccine; 2024 Sep; 42(22):126011. PubMed ID: 38825555
    [TBL] [Abstract][Full Text] [Related]  

  • 64. How enlightened self-interest guided global vaccine sharing benefits all: A modeling study.
    Han Z; Chen L; Hao Q; He Q; Budeski K; Jin D; Xu F; Tang K; Li Y
    J Glob Health; 2023 Dec; 13():06038. PubMed ID: 38115726
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
    Thompson MG; Natarajan K; Irving SA; Rowley EA; Griggs EP; Gaglani M; Klein NP; Grannis SJ; DeSilva MB; Stenehjem E; Reese SE; Dickerson M; Naleway AL; Han J; Konatham D; McEvoy C; Rao S; Dixon BE; Dascomb K; Lewis N; Levy ME; Patel P; Liao IC; Kharbanda AB; Barron MA; Fadel WF; Grisel N; Goddard K; Yang DH; Wondimu MH; Murthy K; Valvi NR; Arndorfer J; Fireman B; Dunne MM; Embi P; Azziz-Baumgartner E; Zerbo O; Bozio CH; Reynolds S; Ferdinands J; Williams J; Link-Gelles R; Schrag SJ; Verani JR; Ball S; Ong TC
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):139-145. PubMed ID: 35085224
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries.
    Marijam A; Schuerman L; Izurieta P; Pereira P; Van Oorschot D; Mehta S; Ota MO; Standaert B
    Hum Vaccin Immunother; 2022 Dec; 18(7):2135916. PubMed ID: 36507685
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Facing the Omicron variant-how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review.
    Külper-Schiek W; Piechotta V; Pilic A; Batke M; Dreveton LS; Geurts B; Koch J; Köppe S; Treskova M; Vygen-Bonnet S; Waize M; Wichmann O; Harder T
    Front Immunol; 2022; 13():940562. PubMed ID: 36091023
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The impact of national income and vaccine hesitancy on country-level COVID-19 vaccine uptake.
    Moradpour J; Shajarizadeh A; Carter J; Chit A; Grootendorst P
    PLoS One; 2023; 18(11):e0293184. PubMed ID: 37917650
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cost-effectiveness of Hepatitis A vaccination in a developed and developing country.
    Ghildayal N
    Int J Health Care Qual Assur; 2019 Oct; 32(8):1175-1199. PubMed ID: 31566514
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study.
    Piernas C; Patone M; Astbury NM; Gao M; Sheikh A; Khunti K; Shankar-Hari M; Dixon S; Coupland C; Aveyard P; Hippisley-Cox J; Jebb SA
    Lancet Diabetes Endocrinol; 2022 Aug; 10(8):571-580. PubMed ID: 35780805
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Targeting and vaccine durability are key for population-level impact and cost-effectiveness of a pox-protein HIV vaccine regimen in South Africa.
    Selinger C; Bershteyn A; Dimitrov DT; Adamson BJS; Revill P; Hallett TB; Phillips AN; Bekker LG; Rees H; Gray G
    Vaccine; 2019 Apr; 37(16):2258-2267. PubMed ID: 30890385
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Urban monitoring, evaluation and application of COVID-19 listed vaccine effectiveness: a health code blockchain study.
    Wang T; Li C; Li H; Li Z
    BMJ Open; 2022 Jul; 12(7):e057281. PubMed ID: 35831042
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile.
    Graña MG; Cavada G; Vasquez M; Shen J; Maervoet J; Klint J; Gómez JA
    Hum Vaccin Immunother; 2021 Dec; 17(12):5603-5613. PubMed ID: 34890520
    [TBL] [Abstract][Full Text] [Related]  

  • 76. COVID-19 vaccination among cirrhotics in Italy: High coverage and effectiveness of 3 doses versus 2 in preventing breakthrough infection and hospitalization.
    Stroffolini T; Ciancio A; Federico A; Benigno RG; Colloredo G; Lombardi A; Niro GA; Verucchi G; Ferrigno L; Gioli F; Marignani M
    Dig Liver Dis; 2023 Mar; 55(3):316-321. PubMed ID: 36529636
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Modeling geographic vaccination strategies for COVID-19 in Norway.
    Chan LYH; Rø G; Midtbø JE; Di Ruscio F; Watle SSV; Juvet LK; Littmann J; Aavitsland P; Nygård KM; Berg AS; Bukholm G; Kristoffersen AB; Engø-Monsen K; Engebretsen S; Swanson D; Palomares AD; Lindstrøm JC; Frigessi A; de Blasio BF
    PLoS Comput Biol; 2024 Jan; 20(1):e1011426. PubMed ID: 38295111
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January-March 2021.
    Sadigh KS; Kugeler KJ; Bressler S; Massay SC; Schmoll E; Milroy L; Cavanaugh AM; Sierocki A; ; Fischer M; Nolen LD
    BMC Infect Dis; 2022 Sep; 22(1):718. PubMed ID: 36050630
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Relative vaccine effectiveness against Delta and Omicron COVID-19 after homologous inactivated vaccine boosting: a retrospective cohort study.
    Tang L; Zhang Y; Wang F; Wu D; Qian ZH; Zhang R; Wang AB; Huang C; Wang H; Ye Y; Lu M; Wang C; Ma YT; Pan J; Li YF; Lv XY; An Z; Rodewald L; Wang XY; Shao YM; Wu ZY; Yin Z
    BMJ Open; 2022 Nov; 12(11):e063919. PubMed ID: 36368753
    [TBL] [Abstract][Full Text] [Related]  

  • 80. India's pragmatic vaccination strategy against COVID-19: a mathematical modelling-based analysis.
    Mandal S; Arinaminpathy N; Bhargava B; Panda S
    BMJ Open; 2021 Jul; 11(7):e048874. PubMed ID: 34215611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.